在美国,乳腺癌患者的发病率和死亡率数据对于医疗保健管理人员规划医疗保健措施(如筛查乳房X光检查)非常重要。在这项研究中,我们使用监测检查了美国2004-2018年的乳腺癌发病率和基于发病率的死亡率,流行病学,和结束结果(SEER)数据库。我们回顾了2004年至2018年诊断的915,417例乳腺癌病例。总的来说,数据显示,所有种族的乳腺癌发病率增加,所有种族的死亡率降低。在研究期间,乳腺癌发病率每年增加0.3%(95%CI,0.1,0.4,p<0.001)。所有年龄段的乳腺癌发病率都有所增加,种族,和除舞台区域外的舞台组,这表明发病率有统计学意义的下降-0.9%(95%CI,-1.1,-0.7,p<0.001)。死亡率下降幅度最高的是白人患者,总体统计学上显著下降-14.3%(95%CI,-18.1,-10.4,p<0.001)。在2016年至2018年期间,发病率下降幅度最大:-48.6(95%CI,-52.6,-44.3,p<0.001)。在黑人/非裔美国患者中,基于发病率的总死亡率下降了-11.6%(95%CI-15.9,-7.1p<.001),在2016年至2018年期间观察到的发生率下降幅度最大,下降幅度为-51.3%(95%CI-56.6,-45.3,p<0.001)。在西班牙裔美国人,基于发病率的总死亡率下降了-12.3%(95%CI-16.9,-7.4,p<.001),低于美国白人。
The incidence and mortality data for patients with breast cancer in the United States are important to healthcare administrators for planning healthcare measures such as screening mammograms. In this study, we examined breast cancer incidence and incidence-based mortality in the United States from 2004-2018 using the Surveillance, Epidemiology, and End Results (SEER) database. We reviewed 915,417 cases of breast cancer diagnosed between 2004 and 2018. Overall, the data showed an increased incidence rate of breast cancer among all races and a decreased mortality rate among all races. Breast cancer incidence rates increased by 0.3% (95% CI, 0.1, 0.4, p<0.001) per year over the study period. Breast cancer incidence rates increased for all age, race, and stage groups except for stage regional, which showed a statistically significant decrease in the incidence of -0.9% (95% CI, -1.1, -0.7, p<0.001). The highest decrease in mortality was observed among white patients, with an overall statistically significant decrease in rates by -14.3% (95% CI, -18.1, -10.4, p <0.001). The highest decrease in rates was observed between 2016 and 2018: -48.6 (95% CI, -52.6, -44.3, p <0.001). In black/African American patients, the overall incidence-based mortality decreased by -11.6% (95% CI -15.9, -7.1 p <.001), with the highest decrease in rates observed between 2016 and 2018 with a decrease of -51.3% (95% CI -56.6, -45.3, p <0.001). In Hispanic Americans, the overall incidence-based mortality decreased by -12.3% (95% CI -16.9, -7.4, p <.001), which is lower than in white Americans.